Clinic
Healthfirst Network INC. F/K/A Family Planning Health Services INC.
Healthfirst Network INC. F/K/A Family Planning Health Services INC. was paid $10.15M by Medicaid between Jan 2018 and Dec 2024, across 51 billing codes. Its largest line is S4993, Contraceptive pills for birth control — 34% of everything it billed.
33Billing provider infoHEALTHFIRST NETWORK INC. F/K/A FAMILY PLANNING HEALTH SERVICES INC.
WAUSAU, WI 54401
WAUSAU, WI 54401
33aNPI1538152491assigned 08/25/2005
28Total paid$10.15M
24GClaims247,665
24DCodes billed51
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Mental Health Clinic/Center (Including Community Mental Health Center) providers in Wisconsin
Rank by total paid#5 of 108
Median peer was paid$332K
This provider vs. median31×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,577 | $797K | |
| 2019 | 26,366 | $968K | |
| 2020 | 31,015 | $1.24M | |
| 2021 | 36,207 | $1.51M | |
| 2022 | 42,729 | $1.81M | |
| 2023 | 50,871 | $2.02M | |
| 2024incomplete | 40,900 | $1.81M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| S4993 | Contraceptive pills for birth control | 34% | 42,470 | 30,557 | $3.43M |
| H1010 | Non-medical family planning education, per session | 25% | 26,379 | 24,234 | $2.49M |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 5.4% | 6,687 | 6,521 | $548K |
| A4267 | Contraceptive supply, condom, male, each | 4.9% | 26,752 | 25,281 | $498K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 4.1% | 7,019 | 6,839 | $420K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 2.9% | 357 | 348 | $293K |
| A4268 | Contraceptive supply, condom, female, each | 2.6% | 26,408 | 24,954 | $262K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.3% | 6,300 | 5,875 | $233K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 2.3% | 7,061 | 6,632 | $233K |
| J7304 | Contraceptive supply, hormone containing patch, each | 2.2% | 590 | 555 | $222K |
| T5999 | Supply, not otherwise specified | 1.6% | 2,306 | 2,098 | $161K |
| 90651 | 1.6% | 756 | 729 | $160K |
39 more codes
| 99214 | Doctor's office visit, returning patient (more involved) | 1.5% | 2,656 | $150K |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | 1.2% | 707 | $121K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.1% | 11,912 | $114K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.1% | 12,517 | $114K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.1% | 4,347 | $109K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,959 | $79K |
| 99385 | <1% | 1,093 | $63K | |
| 86703 | <1% | 4,073 | $53K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 768 | $50K |
| 99000 | <1% | 13,225 | $48K | |
| 81025 | <1% | 5,160 | $43K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 305 | $33K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 5,616 | $28K |
| 86780 | <1% | 3,640 | $28K | |
| 87210 | <1% | 4,808 | $25K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 1,046 | $24K |
| J7295 | Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each | <1% | 619 | $21K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 7,853 | $21K |
| 99201 | <1% | 579 | $13K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 759 | $10K |
| 81002 | <1% | 2,375 | $8K | |
| 58300 | <1% | 170 | $7K | |
| 99401 | <1% | 220 | $6K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 105 | $6K |
| 11981 | <1% | 67 | $5K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 147 | $5K |
| 11982 | <1% | 24 | $2K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 125 | $2K |
| J3490 | Unclassified drugs | <1% | 37 | $936.00 |
| 58301 | <1% | 24 | $747.36 | |
| 99384 | <1% | 13 | $683.52 | |
| 86803 | <1% | 31 | $385.29 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 12 | $249.00 |
| 88142 | <1% | 3,849 | $63.03 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 13 | $8.40 |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 621 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 1,330 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 14 | $0.00 |
| S0197 | Prenatal vitamins, 30-day supply | 0% | 1,761 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWARAKSA, APRIL (CLINIC OPERATIONS SPECIALIST)